Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T08156
(Former ID: TTDI02096)
|
|||||
Target Name |
Interferon-alpha 5 (IFNA5)
|
|||||
Synonyms |
LeIF G; Interferon alphaG; Interferon alpha61; Interferon alpha5; Interferon alpha-G; Interferon alpha-61; Interferon alpha-5; IFNalpha5; IFN-alpha-5
Click to Show/Hide
|
|||||
Gene Name |
IFNA5
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 2 Target-related Diseases | + | ||||
1 | Hepatitis virus infection [ICD-11: 1E50-1E51] | |||||
2 | Postoperative inflammation [ICD-11: 1A00-CA43] | |||||
Function |
Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. Produced by macrophages, IFN-alpha have antiviral activities.
Click to Show/Hide
|
|||||
BioChemical Class |
Cytokine: interferon
|
|||||
UniProt ID | ||||||
Sequence |
MALPFVLLMALVVLNCKSICSLGCDLPQTHSLSNRRTLMIMAQMGRISPFSCLKDRHDFG
FPQEEFDGNQFQKAQAISVLHEMIQQTFNLFSTKDSSATWDETLLDKFYTELYQQLNDLE ACMMQEVGVEDTPLMNVDSILTVRKYFQRITLYLTEKKYSPCAWEVVRAEIMRSFSLSAN LQERLRRKE Click to Show/Hide
|
|||||
3D Structure | Click to Show 3D Structure of This Target | AlphaFold |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 2 Clinical Trial Drugs | + | ||||
1 | Interferon alpha 5 | Drug Info | Phase 1/2 | Infectious disease | [1], [2] | |
2 | NAHE-001 | Drug Info | Phase 1/2 | Hepatitis C virus infection | [1] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 2 Modulator drugs | + | ||||
1 | Interferon alpha 5 | Drug Info | [1] | |||
2 | NAHE-001 | Drug Info | [1] |
Cell-based Target Expression Variations | Top | |||||
---|---|---|---|---|---|---|
Cell-based Target Expression Variations |
Different Human System Profiles of Target | Top |
---|---|
Human Similarity Proteins
of target is determined by comparing the sequence similarity of all human proteins with the target based on BLAST. The similarity proteins for a target are defined as the proteins with E-value < 0.005 and outside the protein families of the target.
A target that has fewer human similarity proteins outside its family is commonly regarded to possess a greater capacity to avoid undesired interactions and thus increase the possibility of finding successful drugs
(Brief Bioinform, 21: 649-662, 2020).
Human Pathway Affiliation
of target is determined by the life-essential pathways provided on KEGG database. The target-affiliated pathways were defined based on the following two criteria (a) the pathways of the studied target should be life-essential for both healthy individuals and patients, and (b) the studied target should occupy an upstream position in the pathways and therefore had the ability to regulate biological function.
Targets involved in a fewer pathways have greater likelihood to be successfully developed, while those associated with more human pathways increase the chance of undesirable interferences with other human processes
(Pharmacol Rev, 58: 259-279, 2006).
Human Similarity Proteins
Human Pathway Affiliation
|
There is no similarity protein (E value < 0.005) for this target
|
KEGG Pathway | Pathway ID | Affiliated Target | Pathway Map |
---|---|---|---|
Cytokine-cytokine receptor interaction | hsa04060 | Affiliated Target |
|
Class: Environmental Information Processing => Signaling molecules and interaction | Pathway Hierarchy | ||
PI3K-Akt signaling pathway | hsa04151 | Affiliated Target |
|
Class: Environmental Information Processing => Signal transduction | Pathway Hierarchy | ||
Necroptosis | hsa04217 | Affiliated Target |
|
Class: Cellular Processes => Cell growth and death | Pathway Hierarchy | ||
Toll-like receptor signaling pathway | hsa04620 | Affiliated Target |
|
Class: Organismal Systems => Immune system | Pathway Hierarchy | ||
NOD-like receptor signaling pathway | hsa04621 | Affiliated Target |
|
Class: Organismal Systems => Immune system | Pathway Hierarchy | ||
RIG-I-like receptor signaling pathway | hsa04622 | Affiliated Target |
|
Class: Organismal Systems => Immune system | Pathway Hierarchy | ||
Cytosolic DNA-sensing pathway | hsa04623 | Affiliated Target |
|
Class: Organismal Systems => Immune system | Pathway Hierarchy | ||
JAK-STAT signaling pathway | hsa04630 | Affiliated Target |
|
Class: Environmental Information Processing => Signal transduction | Pathway Hierarchy | ||
Natural killer cell mediated cytotoxicity | hsa04650 | Affiliated Target |
|
Class: Organismal Systems => Immune system | Pathway Hierarchy | ||
Click to Show/Hide the Information of Affiliated Human Pathways |
Target Affiliated Biological Pathways | Top | |||||
---|---|---|---|---|---|---|
KEGG Pathway | [+] 15 KEGG Pathways | + | ||||
1 | Cytokine-cytokine receptor interaction | |||||
2 | Regulation of autophagy | |||||
3 | PI3K-Akt signaling pathway | |||||
4 | Toll-like receptor signaling pathway | |||||
5 | RIG-I-like receptor signaling pathway | |||||
6 | Cytosolic DNA-sensing pathway | |||||
7 | Jak-STAT signaling pathway | |||||
8 | Natural killer cell mediated cytotoxicity | |||||
9 | Tuberculosis | |||||
10 | Hepatitis C | |||||
11 | Hepatitis B | |||||
12 | Measles | |||||
13 | Influenza A | |||||
14 | Herpes simplex infection | |||||
15 | Autoimmune thyroid disease | |||||
PID Pathway | [+] 2 PID Pathways | + | ||||
1 | Downstream signaling in naï | |||||
2 | ||||||
Reactome | [+] 4 Reactome Pathways | + | ||||
1 | Interferon alpha/beta signaling | |||||
2 | Regulation of IFNA signaling | |||||
3 | TRAF6 mediated IRF7 activation | |||||
4 | Factors involved in megakaryocyte development and platelet production | |||||
WikiPathways | [+] 3 WikiPathways | + | ||||
1 | Toll-like receptor signaling pathway | |||||
2 | Interferon alpha/beta signaling | |||||
3 | Regulation of toll-like receptor signaling pathway |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Interferons and viral infections. Biofactors. 2009 Jan-Feb;35(1):14-20. | |||||
REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4963). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.